TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY

Benzinga Newsdesk www.benzinga.com Negative 95.8%

Neg 95.8% Neu 0% Pos 0%

TherapeuticsMD (NASDAQ:TXMD) reported quarterly losses of $(0.06) per share. This is a 700 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $893.000 thousand in sales this quarter. This is a 33.88 percent increase over sales of $667.000 thousand the same period last year.